By HempTalk on Friday, 05 June 2026
Category: Project CBD Newsfeed

Project CBD Newsletter: Cannabis and Sleep Brain Activity, CBD for Pain and Alzheimer’s, Fibromyalgia Trial Results, and Cannabis Policy Updates

This week’s newsletter covers new research on how cannabis affects brain activity during sleep, promising findings on CBD’s role in pain management and Alzheimer’s disease, a clinical trial on cannabis oil for fibromyalgia, and a roundup of notable cannabis policy developments across the United States.

Noteworthy Read

How a Dose of Medicinal Cannabis Alters Brain Waves During Sleep (PsyPost)

A sleep study found that a dose of medicinal cannabis changed brain activity during sleep, including reductions in total sleep time and REM sleep compared to placebo. The findings are a useful reminder that cannabis may affect sleep in complex ways, even when patients use it to help them fall asleep or improve sleep quality.

Read the full article

View more in THC

More Noteworthy Reading

CBD Enhances Oxycodone’s Pain Relieving Effects (Pain News Network)

New animal research suggests CBD may strengthen oxycodone’s pain-relieving effects while reducing opioid self-administration, pointing to a possible role for cannabinoids in future opioid-sparing pain strategies.

Read more

View more in Drug Interactions

Clinical Trial: Cannabis Oil Improves Fibromyalgia Symptoms (NORML)

A clinical trial found that cannabis oil produced meaningful improvements in fibromyalgia symptoms, including pain, sleep quality, quality of life, and overall disease impact. NORML reports that 70% of participants in the treatment group achieved clinically meaningful pain relief.

Read more

View more in CBD

CBD May Slow Alzheimer’s by Calming Brain’s Immune System (ScienceDaily)

New mouse research suggests inhaled CBD may reduce neuroinflammation in Alzheimer’s disease by calming overactive immune responses in the brain. The findings point to CBD’s potential relevance in neurodegenerative disease research, though the work remains preclinical.

Read more

View more in CBD

Research Round-Up

ASA Outlines Patient Rights After Medical Cannabis Rescheduling (Ganjapreneur)

Cannabis advocacy organization Americans for Safe Access (ASA) on Tuesday released a new medical cannabis patient and caregiver guide designed to help individuals understand and exercise their rights under the federal reclassification of medical cannabis from Schedule I to Schedule III under the Controlled Substances Act.

Read more

View more in CBD

Louisiana Gov. Signs Bill Enhancing Penalties for Smoking Cannabis on College Campuses (Ganjapreneur)

Louisiana Gov. Jeff Landry (R) has signed a bill that will jail individuals for smoking cannabis within 2,000 feet of high school and college campuses. In a statement posted to X last week, Landry said he was “tired of going…to college and high school campuses and being inundated with the smell of marijuana.”

Read more

View more in THC

Kentucky Gov. Signs Order to Add 15 New Qualifying Conditions for Medical Cannabis (Ganjapreneur)

Kentucky Gov. Andy Beshear issued an executive order to clarify medical cannabis questions and add 15 qualifying conditions to the state program. The conditions include Arthritis, Parkson’s disease, Glaucoma, Neuropathies, and terminal illnesses in general, among numerous others.

Read more

View more in CBD

UFCW Joins Calls for Release of Federal Prisoners Convicted of Non-Violent Cannabis Crimes (Ganjapreneur)

The United Food and Commercial Workers International (UFCW) union is joining Democratic lawmakers in their request that President Donald Trump pardon everyone in prison for all non-violent cannabis crimes.

Read more

View more in CBD

Massachusetts Regulators to Audit Cannabis THC Potency Levels (Ganjapreneur)

The Massachusetts Cannabis Control Commission (CCC) announced recently that the agency will begin auditing the THC potency levels of retail cannabis products. The audits will test products from the regulated market for THC potency, and if the test results report something outside of 75 to 125% what is listed on the label, the product will be removed from store shelves.

Read more

View more in THC

A heartfelt thank you to all of the CBD brands whose generous support makes it possible for Project CBD to bring you the latest in plant medicine research and cannabis news each week — we couldn’t do it without you.

The post Project CBD Newsletter: Cannabis and Sleep Brain Activity, CBD for Pain and Alzheimer’s, Fibromyalgia Trial Results, and Cannabis Policy Updates appeared first on Project CBD.

Original link
Leave Comments